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Abstract The availability of repeating ‘Cys’ and/or ‘His’ units
in a particular order prompts the prediction of Zn(II) finger
motifs in a protein. Escherichia coli RNA polymerase has two
tightly bound Zn(II) per molecule of the enzyme as detected by
atomic absorption spectroscopy. One Zn(II) was identified to be
at the L subunit, whereas the other putative Zn(II) binding site
has recently been predicted to be at the N-terminal half of the LP
subunit, from primary sequence analysis. We show here that the
LP subunit has no ability to bind 65Zn(II). On the other hand, the
N-terminal domain of the K subunit has strong Zn(II) binding
ability with no obvious functional implications.
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1. Introduction
In nature, a variety of enzymes like nucleotidyl transferases
including DNA and RNA polymerases are known to contain
stoichiometric amounts of Zn(II) [1,2]. Some of these Zn(II)
are known to be functional [3] whereas others may have a
structural role. The most common method for Zn(II) deter-
mination has been atomic absorption spectroscopy (AAS)
[4,5] where even 1 ppb Zn(II) could be detected at 213.8
nM [4,6]. However, AAS remains a destructive technique for
element detection. Thus, there is a continuing e¡ort to identify
Zn(II) binding sites in a macromolecule with an improved
technique and to assign a functional role to it, if any.
With the discovery of the tandem Zn(II) ¢nger motif [7,8] in
transcription factor TFIIIA, it became apparent that the ¢ne
tuning of DNA-protein recognition may be carried out by
Zn(II) ions. Thus prediction of such motifs in DNA binding
proteins from the primary sequence and then ascribing a role
to them has resulted in some very important conclusions in
many areas of biology [9,10]. However, one of the di⁄culties
that remain is to correlate the number of Zn(II) ions present
in a protein molecule with the putative binding sites. Xenopus
TFIIIA shows nine ¢nger motifs [7] but AAS estimates only
two Zn(II) per molecule of the protein [11]. Such contradic-
tory results are perhaps due to extensive dialysis of the pro-
teins in 10 mM EDTA containing bu¡er to remove non-stoi-
chiometric loosely bound Zn(II) which may ultimately remove
some of the Zn(II) bound to ¢nger motifs.
The other most common method for the determination of
Zn(II) is to exchange bound Zn(II) with radioactive 65Zn(II)
on a nitrocellulose membrane which was previously blotted
with the protein [12,13]. Subsequent autoradiography of the
membrane would reveal the protein having radioactivity asso-
ciated with it. The implicit assumption in this case is that the
bound Zn(II) is not lost from the protein during Western
transfer to the membranes. Amino acid sequence analysis of
RNA polymerase II followed by 65Zn(II) blotting indicates
the presence of ¢ve potential Zn(II) binding sites [14]; how-
ever, AAS of the enzyme shows the presence of two Zn(II) per
molecule of the multimeric protein [15]. Another in vitro
method for detection of Zn(II) involves the use of a £uores-
cent probe, N-(6-methoxy-8-quinoyl)-p-toluenesulfonamide
(TSQ). This probe is Zn(II) speci¢c [16] and is capable of
ejecting Zn(II) from its environment in a protein with con-
comitant £uorescence change of TSQ, thereby allowing the
quantitation of the ejected metal ion. A third method is an
in vivo approach where a mutation in the putative Zn binding
site of a protein rendering it inactive can be rescued by growth
of the strain on plates supplemented with exogenous Zn(II)
[17,18]. Each of the above mentioned methods has its advan-
tages and limitations and in this study we aim to highlight one
such fallibility of the 65Zn blotting technique using Escherichia
coli RNA polymerase.
2. Materials and methods
All chemicals used were of analytical grade.65ZnCl2(speci¢c activity
2.38 mCi/mg) was purchased from NEN Life Sciences, DuPont. All
enzymes were purchased from New England Biolabs.
2.1. Plasmid construction and protein puri¢cation
The overexpression plasmid pGEMAX185 containing the K subunit
of RNA polymerase was a kind gift from Akira Ishihama, NIG (Ja-
pan). The plasmid pRW308 containing the LP subunit of E. coli RNA
polymerase was a kind gift from Robert Landick [19]. K230 is a C-
terminal truncated protein constructed by digestion of pGEMAX185
with HindIII followed by self ligation of the larger fragment. The v40
mutant was constructed as described by Kimura et al. [20]. The in-
ternal deletion mutant v111^156 was constructed by digestion of
pGEMAX185 with EcoRI and PstI followed by self ligation of the
blunted larger fragment. The triple His mutant was constructed by site
directed mutagenesis by Kunkel’s method [21].
Wild type and mutant K subunit puri¢cations were essentially car-
ried out as described by Igarashi et al. [22]. RNA polymerase was
puri¢ed according to the method of Hager et al. [23]. Radioactive
Zn(II) blotting was done as described by Mazen et al. [12]. The pro-
teins were fractionated by SDS-PAGE and transferred on to a nitro-
cellulose membrane after the gel was incubated in a bu¡er containing
5% L-mercaptoethanol. The blot was then renatured, incubated with
radioactive Zn(II), washed and autoradiographed.
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3. Results
3.1. The LPsubunit of E. coli RNA polymerase does not bind
65Zn(II)
E. coli RNA polymerase is a Zn containing metalloenzyme
having two tightly bound Zn(II) per molecule of the enzyme
[1]. One of us several years ago had located one Zn(II) at the
L subunit which can be replaced with other divalent metals
under suitable conditions [5]. AAS tentatively assigned the
other Zn(II) at the LPsubunit [24]. Later, sequence analysis
carried out simultaneously by us and another group showed
the presence of a putative Zn ¢nger domain at the N-terminal
of the LP subunit [25,26]. In order to check for the ability of
the individual large subunits to bind Zn(II), puri¢ed L and LP
subunits as well as the holo RNA polymerase were subjected
to 65Zn(II) blotting. Fig. 1 shows that contrary to the predic-
tion, the LP subunit does not light up in the 65Zn(II) blot
whereas the L subunit shows strong 65Zn(II) binding. Molec-
ular weight markers also show 65Zn(II) binding wherever the
proteins are known to be Zn(II) containing metalloproteins.
3.2. The K subunit of E. coli RNA polymerase binds Zn(II)
Fig. 2, lane 5 shows the 65Zn(II) blot of holo RNA polym-
erase. It can be seen from the ¢gure that the K subunit binds
65Zn(II). Upon sequence analysis of the K subunit (Fig. 3) we
could ¢nd at least two ‘Cys’ and ‘His’ clusters at its N-termi-
nal domain which are known to be potential ligands for
Zn(II). However, no well de¢ned Zn ¢nger motifs were notice-
able. Next, the entire region between amino acids 111 and 156
in the K subunit containing three ‘His’ residues and one ‘Cys’
residue was deleted to generate a mutant K subunit which we
designated v111^156. Similarly a mutant K, v40 was gener-
ated which was devoid of the ¢rst 40 amino acids from the N-
terminal domain containing two ‘His’ residues at positions 23
and 37. Fig. 2, lane 3 (v111^165) shows a markedly reduced
65Zn(II) binding ability compared with the wild type K sub-
unit while lane 2 (v40) shows a reduction to a lesser extent.
On the other hand, a C-terminal deleted mutant, K230 which
only contains the ¢rst 230 amino acids from N-terminal do-
main, lights up strongly with 65Zn(II) (lane 4). That the bind-
ing of 65Zn(II) to the K subunit was speci¢c to a site was
suggested when a serial titration experiment was performed
to compete out 65Zn(II) with cold ZnCl2 (Fig. 4).
We have obtained a temperature sensitive E. coli strain
HN317 from Akira Ishihama, Japan which grows very well
at 30‡C but does not grow at 42‡C. It was found that this
growth defect is due to a point mutation R45A at the N-
terminal domain of the K subunit [27] rendering it assembly
defective at 42‡C. As expected, this growth defect could be
rescued when the rpoA gene which encodes the K subunit was
supplied through a plasmid. We obtained a variant of the K
subunit where all three ‘His’ residues at positions 117, 128 and
Fig. 1. 65Zn(II) blotting of the large subunits of E. coli RNA po-
lymerase. Lane 1, puri¢ed LP subunit (10 Wg); lane 2, puri¢ed L sub-
unit (10 Wg). Lane M, molecular weight markers (Pharmacia) con-
sisting of phosphorylase b (94 kDa), bovine serum albumin
(67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soy-
bean trypsin inhibitor (20 kDa) and K-lactalbumin (14 kDa).
Fig. 2. 65Zn(II) blotting of wild type and mutant K subunits of E.
coli RNA polymerase. Lane 1, puri¢ed wild type K subunit; lane 2,
v40; lane 3, v111^156; lane 4, K230; lane 5, E. coli RNA polymer-
ase. Lane M, molecular weight markers (Pharmacia).
Fig. 3. Schematic representation of the positions of Cys (closed tri-
angles) and His (open triangles) on the primary sequence of the K
subunit of E. coli RNA polymerase.
Fig. 4. Titration of 65Zn(II) blot of the wild type K subunit with
various molar ratios of 65ZnCl2 to cold ZnCl2. Lane 1, 1:20; lane
2, 1:10; lane 3, 1:5; lane 4, 1:2.5.
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132 were mutated to ‘R’ and we designated the gene
H117,128,132R. The product of this gene does not show
any 65Zn(II) binding in a typical 65Zn(II) blotting experiment
(not shown). However, this triple mutant was able to comple-
ment the growth of E. coli strain HN317 at 42‡C indicating
the three ‘His’ residues and Zn(II) binding may not have any
direct e¡ect on RNA polymerase assembly.
4. Discussion
In this report we have demonstrated that the 65Zn blotting
technique, which is a powerful tool to detect zinc binding
proteins, does not necessarily indicate their putative binding
sites. Estimation of Zn content of individual subunits by AAS
indicates the c and K subunits to contain less than 0.1 g atom
of Zn/mol of enzyme while the L and LP subunits contain
0.6 þ 0.3 and 1.4 þ 0.5 g atoms/mol of the proteins respectively
[28]. In the light of these data and the results of the Zn blot-
ting assay of RNA polymerase subunits, it is perhaps not
unreasonable to interpret the complete stoichiometric binding
of Zn to the core RNA polymerase as a consequence of sub-
unit interfaces in the enzyme rather than by individual sub-
units.
The inability of the Zn blotting technique to detect the
putative Zn binding site in the LP subunit could be viewed
as indicating this site to be ‘conformational’ [13] wherein the
amino acid residues (C70, C72, C85 and C88), though not too
far apart on the primary sequence, require more than minimal
renaturation to recreate the Zn binding pocket on the LP sub-
unit. Alternatively the metal binding pocket of the LP subunit
could be an interface contributed by the L subunit and per-
haps even the K subunit. Another limitation of the Zn(II) blot
and the other in vitro techniques is that they do not indicate
the functional signi¢cance of the metal associated with the
metalloproteins. The in vivo assay described by Johnston
[17] has been used very e¡ectively in combination with
Zn(II) blotting to address the in vivo relevance of metal bind-
ing [18].
In the same line of thought, we have identi¢ed and localized
the Zn(II) binding site on the K subunit and used the in vivo
assay to study its functional signi¢cance. The triple His mu-
tant of the K subunit was unable to bind Zn(II), yet could
complement the K temperature sensitive strain HN317. In our
opinion, the possible explanation for this result is that either
exogenous Zn(II) was picked up by the mutated K during
growth or Zn(II) has no role to play in maintaining confor-
mation of the K subunit necessary for folding and assembly.
Lastly, we would like to point out that although AAS is the
best method for correctly estimating the number of strongly
bound Zn(II) present with a protein, it fails to identify other
loosely bound Zn(II) which may play important functional
roles. They are lost during sample preparation for AAS as
mentioned before. This problem is compounded by the fact
that Zn(II) is an abundant metal which is non-speci¢cally
associated with proteins and thus dialysis against a strong
chelator is necessary before any AAS measurements. 65Zn(II)
blotting experiments appear to pick up these weakly bound
but functionally important Zn(II). Thus, any estimate of
Zn(II) sites in a protein by 65Zn(II) blotting is higher than
those measured by AAS. However, the discrepancy between
65Zn(II) blotting and prediction of putative Zn(II) ¢nger in
the LP subunit as pointed out here raises further alarm to-
wards assigning the Zn(II) ¢nger from the primary sequence
alone.
Acknowledgements: The authors wish to thank Prof. Akira Ishihama
for kind gifts of strains and plasmids at various points of this work
and Dr. Meera Patturajan, The Johns Hopkins University, USA, for
initial standardization. S.S. is the recipient of a University Grants
Commission fellowship. Part of this work has also been sponsored
by the Department of Science and Technology, Government of India.
References
[1] Scrutton, M.C., Wu, C.W. and Goldthwait, D.A. (1971) Proc.
Natl. Acad. Sci. USA 68, 2497^2501.
[2] Mildvan, A.S. and Loeb, L.A. (1979) CRC Crit. Rev. Biochem.
6, 219^244.
[3] Vallee, B.L. and Galdes, A. (1984) Adv. Enzymol. 56, 283^430.
[4] Speckhard, D.C., Wu, F.Y.H. and Wu, C.W. (1977) Biochemis-
try 16, 5228^5234.
[5] Chatterji, D. and Wu, F.Y.H. (1982) Biochemistry 21, 4651^
4656.
[6] Solaiman, D. and Wu, F.Y.H. (1985) Biochemistry 24, 5077^
5083.
[7] Miller, J., McLachlan, A.D. and Klug, A. (1985) EMBO J. 4,
1609^1614.
[8] Rhodes, D. and Klug, A. (1986) Cell 46, 123^132.
[9] Page, D.C., Mosher, R., Simpson, E.M., Fisher, E.M., Mardon,
G., Pollack, J., McGillivray, B., de la Chapelle, A. and Brown,
L.G. (1987) Cell 46, 123^132.
[10] Rice, W.G., Schae¡er, C.A., Harten, B., Villinger, F., South,
T.L., Summers, M.F., Henderson, L.E., Bess, J.W., Authur,
L.O., McDougal, J.S., Orlo¡, L.S., Mendeleyev, J. and Kun, E.
(1993) Nature 361, 473^478.
[11] Hanas, J.S., Hazuda, D.J., Bogenhagen, D.F., Wu, F.Y.H. and
Wu, C.W. (1983) J. Biol. Chem. 258, 14120^14125.
[12] Mazen, A., Gradwohl, G. and de Murcia, G. (1988) Anal. Bio-
chem. 172, 39^42.
[13] Schi¡, L.A., Nibert, M.L. and Fields, B.N. (1988) Proc. Natl.
Acad. Sci. USA 85, 4195^4199.
[14] Treich, I., Riva, M. and Sentenac, A. (1991) J. Biol. Chem. 266,
21971^21976.
[15] Mayalagu, S., Patturajan, M. and Chatterji, D. (1997) Gene 190,
77^85.
[16] Tummino, P.J., Scholten, J.D., Harvey, P.J., Holler, T.P., Malo-
ney, L. and Gogliotti, R. (1996) Proc. Natl. Acad. Sci. USA 93,
969^973.
[17] Johnston, M. (1987) Nature 328, 353^355.
[18] Landro, J.A. and Schimmel, P. (1994) J. Biol. Chem. 269, 20217^
20220.
[19] Weilbaecher, R., Hebron, C., Feng, G. and Landick, R. (1994)
Genes Dev. 8, 2913^2927.
[20] Kimura, M., Fujita, N. and Ishihama, A. (1994) J. Mol. Biol.
242, 107^115.
[21] Kunkel, T.A., Bebenek, K. and McClary, J. (1991) Methods
Enzymol. 204, 125^139.
[22] Igarashi, K. and Ishihama, A. (1991) Cell 65, 1015^1022.
[23] Hager, D., Jin, D. and Burgess, R.R. (1990) Biochemistry 29,
7890^7894.
[24] Miller, J.A., Serio, G.F., Howard, R.A., Bear, J.L. and Evans,
J.E. (1979) Biochim. Biophys. Acta 579, 291^297.
[25] Chatterji, D. and Guruprasad, K. (1988) Curr. Sci. 57, 376^377.
[26] Zaychikov, E., Martin, E., Denissova, L., Kozlov, M., markovt-
sov, V., Kashlev, M., Heumann, H., Nikiforov, V., Goldfarb, A.
and Mustaev, A. (1996) Science 273, 107^109.
[27] Ishihama, A., Shimamoto, N., Aiba, H. and Kawakami, H.
(1980) J. Mol. Biol. 137, 137^150.
[28] Wu, C.W., Wu, F.Y. and Speckhard, D.C. (1977) Biochemistry
16, 5449^5454.
FEBS 22239 25-6-99
S. Sujatha, D. Chatterji/FEBS Letters 454 (1999) 169^171 171
